Company
Zetagen Therapeutics
| Industry | privately held, clinical-stage biopharmaceutical company praised over $12M in Series B1 funding |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Zetagen Therapeutics | Series B1 | 2025-11-26 |
| Zetagen Therapeutics | Series B Funding | 2023-08-11 |